rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

QT Imaging Holdings, Inc.

QTI · Nasdaq

Health CareMedical DevicesNot moving yet

QTI stood above a rising 150-day average in 1 of the last 52 weekly readings, and has been out of that trend for the last 51 weeks. It is 44.0% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 51
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$310K
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
29 (+9)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 1 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$2.2MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months1
Sale orders, 12 months0
Buyers · sellers1 · 0
WhoDidSharesTraded
Avi S. KatzCHAIRMANbought24,107at $6.4322 Jan 2026filed 23 Jan 2026
Avi S. KatzCHAIRMANbought48,214at $0.0022 Jan 2026filed 23 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders29+9 on the quarter
New · exited10 · 1
Reported value$13.3M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Lynrock Lake LPreduced · filed 14 Aug 20261,112,201$4.5M-42,387−3.7%
Alyeska Investment Group, L.P.unchanged · filed 14 Aug 2026702,776$2.9M00.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026356,448$1.5M+334,522+1525.7%
Bleichroeder LPadded · filed 13 Aug 2026316,667$1.3M+150,001+90.0%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026135,418$551K-6,362−4.5%
CITADEL ADVISORS LLCnew · filed 14 Aug 2026114,099$464K+114,099
PERKINS CAPITAL MANAGEMENT INCnew · filed 24 Jul 2026100,000$407K+100,000
Stonepine Capital Management, LLCnew · filed 14 Aug 2026100,000$407K+100,000
BlackRock, Inc.added · filed 7 Aug 202661,353$250K+33,009+116.5%
MILLENNIUM MANAGEMENT LLCreduced · filed 14 Aug 202655,340$225K-14,804−21.1%

News

No headline names it lately.

Everyone who traded it

Raluca Dinu Company insiderChief Executive Officer · last 28 Aug 20263 · 0
Bryan Timm Company insiderDirector · last 4 Aug 20260 · 0
Avi S. Katz Company insiderChairman · last 20 Mar 20262 · 0
Daniel H. Dickson Company insiderDirector · last 20 Mar 20261 · 0
James S. Greene Company insiderDirector · last 20 Mar 20261 · 0
Jay Walter Jennings Company insiderChief Financial Officer · last 20 Mar 20260 · 0
John C. Klock Jr. Company insiderDirector, 10% owner · last 20 Mar 20260 · 0
Ross Taylor Company insiderDirector · last 20 Mar 20261 · 0
Zeev Weiner Company insiderDirector · last 20 Mar 20261 · 0
Anastas Budagov Company insiderChief Financial Officer · last 21 Apr 20250 · 0
Gigacquisitions5, Llc Company insider10% owner · last 21 Mar 20252 · 0
Gerald McMorrow Company insiderDirector · last 4 Mar 20240 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202545.4%
Operating profit marginFY 2025 · to 31 Dec 2025-23.4%
Free cash flow marginFY 2025 · to 31 Dec 2025-48.0%
Return on capital employedFY 2025 · to 31 Dec 2025-29.3%
Debt to equityFY 2025 · to 31 Dec 20251.57×
Research spendFY 2025 · to 31 Dec 202520.8%
Share count trendFY 2025 · to 24 Mar 20261.2%
Cash and equivalentsFY 2025 · to 31 Dec 2025$10.4M
Free cash flowFY 2025 · to 31 Dec 2025−$9.1M

Analyst forecasts

No analyst forecasts yet.